Eirgen Pharma’s 2025 Gender Pay Gap Report outlines the organisation’s current gender representation, pay gap metrics, and actions to foster a more inclusive and equitable workplace. Eirgen, a research-driven specialist in high-potency human and veterinary oral solid dose products, employs over 160 people at its Waterford site and is committed to maintaining dignity, respect, and diversity across the workforce.

This report highlights a significant improvement, with the gender pay gap decreasing from 15.3% in 2024 to 10.3% in 2025—largely driven by strong internal development of female talent, with 56% of promotions awarded to women, and 52% of leadership roles now held by women.

The report explains the factors influencing mean and median pay gaps across full-time, part-time, and temporary employees and notes that disparities often stem from gender representation at different organisational levels rather than unequal pay for equal work.

Please read our full report below for more information.

Eirgen Pharma - Gender Pay Gap Report 2025.pdf

Download PDF • 585KB